Status:

UNKNOWN

Vitamin D Supplementation for the Prevention of GDM

Lead Sponsor:

Women's Hospital School Of Medicine Zhejiang University

Conditions:

Vitamin D

Gestational Diabetes

Eligibility:

FEMALE

18-45 years

Phase:

EARLY_PHASE1

Brief Summary

This study was a double-blind multicenter randomized controlled study.

Detailed Description

This study intends to adopt a randomized controlled study design, and randomly divide pregnant women at high risk of GDM into intervention group (VitD3:1600 IU/ day) (n=800) and control group (placebo...

Eligibility Criteria

Inclusion

  • Pregnant women who are 8 to 14 weeks pregnant ; ② 18 to 45 years old; ③ Pregnant women at high risk of GDM (meeting any of the following conditions) : A) BMI ≥24 kg/m2 before or during pregnancy; B) family history of diabetes or GDM; C) Previous pregnancy diagnosed as GDM; D) with a history of macrosomia (≥4000 g); E) A history of abnormal glucose tolerance: 5.7-6.4% hBA1c or 6.1-7.0 mmol/L fasting blood glucose.
  • Sign informed consent. -

Exclusion

  • Patients with a history of diabetes or currently diagnosed diabetes (including type 1 and type 2 diabetes);
  • HBA1c ≥6.5% or fasting blood glucose \& GT;7.0 mmol/L with obvious symptoms of diabetes;
  • Patients with current or past abnormalities in calcium metabolism (hypoparathyroidism/hyperthyroidism, kidney stones), high urinary calcium or hypercalcemia;
  • Daily VitD intake \& GT;800 IU. ⑤ Suffering from serious chronic diseases (heart, lung, liver, kidney and other dysfunction) or mental illness;
  • They cannot walk 100 meters safely; 7. Multiple pregnancies or assisted reproduction; ⑧ need complex diet;
  • Cannot speak Mandarin fluently; ⑩ Those who are participating in other clinical trials or who are considered unsuitable for clinical trials by researchers for other reasons.

Key Trial Info

Start Date :

January 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2025

Estimated Enrollment :

1600 Patients enrolled

Trial Details

Trial ID

NCT05208827

Start Date

January 1 2022

End Date

January 1 2025

Last Update

January 26 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Women's Hospital School of Medicine Zhejiang University

Hangzhou, Zhejiang, China, 310000

Vitamin D Supplementation for the Prevention of GDM | DecenTrialz